
Endo International plc ENDP
Annual report 2023
added 03-06-2024
Endo International plc DIO Ratio 2011-2026 | ENDP
Annual DIO Ratio Endo International plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 | 93.2 | 95 | 86 | 76.3 | 72.1 | 64.1 | 77 | 131 | 123 | 131 | 104 | 89.9 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 131 | 64.1 | 95.6 |
Quarterly DIO Ratio Endo International plc
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109 | 109 | 110 | - | 101 | 98.9 | 94.8 | - | 101 | 100 | 107 | - | 92.3 | 95.6 | 79.8 | - | 76.9 | 77.1 | 75.7 | - | 71.2 | 77 | 80.7 | - | 69.4 | 66.2 | 64.6 | - | 91 | 80.2 | 86.7 | - | 155 | 156 | 139 | - | 113 | 127 | 160 | - | 133 | 125 | 67.2 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 160 | 64.6 | 99.7 |
DIO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
133 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | ||
|
Assertio Holdings
ASRT
|
322 | $ 18.02 | - | $ 115 M | ||
|
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
460 | - | - | $ 50.1 M | ||
|
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | ||
|
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B | ||
|
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
239 | $ 3.09 | -0.64 % | $ 43.4 M | ||
|
Cronos Group
CRON
|
221 | $ 2.58 | 1.18 % | $ 1.34 B | ||
|
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | ||
|
Bausch Health Companies
BHC
|
172 | $ 5.6 | 3.9 % | $ 2.04 B | ||
|
Harrow Health
HROW
|
65.1 | $ 35.93 | -3.65 % | $ 1.32 B | ||
|
Aurora Cannabis
ACB
|
1.35 K | $ 3.43 | -1.44 % | $ 86.3 M | ||
|
Canopy Growth Corporation
CGC
|
167 | $ 1.05 | -3.67 % | $ 113 M | ||
|
Jupiter Wellness
JUPW
|
80.2 | - | - | $ 33.6 M | ||
|
OrganiGram Holdings
OGI
|
2.83 K | $ 1.4 | -2.78 % | $ 402 M | ||
|
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | ||
|
Evolus
EOLS
|
71.3 | $ 4.27 | 0.71 % | $ 275 M | ||
|
Emergent BioSolutions
EBS
|
176 | $ 7.96 | -5.8 % | $ 408 M | ||
|
Organogenesis Holdings
ORGO
|
85.9 | $ 2.38 | 3.93 % | $ 313 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 23.79 | -0.13 % | $ 1.1 B | ||
|
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | ||
|
ProPhase Labs
PRPH
|
30.1 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
97.2 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
117 | $ 2.28 | -5.39 % | $ 2.83 M | ||
|
Tilray
TLRY
|
170 | $ 6.57 | -2.23 % | $ 4.06 B | ||
|
Veru
VERU
|
179 | $ 2.38 | -2.06 % | $ 321 M | ||
|
Viatris
VTRS
|
140 | $ 13.47 | -1.03 % | $ 16.2 B | ||
|
cbdMD
YCBD
|
165 | $ 0.68 | 4.01 % | $ 2.93 M | ||
|
Zomedica Corp.
ZOM
|
187 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
29.2 | $ 0.91 | -2.17 % | $ 32.7 M | ||
|
China Pharma Holdings
CPHI
|
166 | $ 0.63 | -3.82 % | $ 2.7 M | ||
|
TherapeuticsMD
TXMD
|
1.04 K | $ 2.07 | 0.98 % | $ 23.9 M |